LIQUIDIA CORPORATION
LQDA · Healthcare · $7.0B mkt cap · FY2025 filings · No moat ·
Doesn't clear the bar
The four filters
Median gross margin 76.5% over 5y, stable.
Median ROIC -163.4%, above the 9% hurdle in 0% of years.
Net debt/EBITDA n/ax, interest coverage -2x.
Owner earnings trend unclear, share count growing (dilution).
Margin of safety
- Owner earnings (normalized)
- —
- Est. intrinsic value / share
- —
- Recent price
- $79.94
- Discount to value
- No price data
Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).
8 years of fundamentals
The business, in plain English
Across the filed record, revenue grew from $8.1M (FY2019) to $158.3M (FY2025) — about 64.2% a year compounded over 6 years.
It earned −180.0% on invested capital in FY2022, with a median of −163.4% across 4 filed years. The Returns on Capital filter above scores it 0/100.
The balance sheet carried $19.9M of total debt in FY2022. Balance-Sheet Safety scores it 28/100.
The share count rose 208.9% between FY2019 and FY2025 — existing owners have been diluted over the record. Capital Discipline scores it 24/100.
Put together: Pricing Power is the strongest of the four filters (87/100) and Returns on Capital the weakest (0/100), which is how LQDA lands at 37/100 — a None moat.
This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.
Gaps in a line mean that item isn’t in LQDA’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.
Moat Score history
Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
None yet — LQDA has read No moat for every logged capture since Jul 17, 2026.
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Healthcare context
#284 of 440 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #282GKOS GLAUKOS Corp36.5 out of 100, No moatNo moat
- #283SCNX Scienture Holdings, Inc.36.5 out of 100, No moatNo moat
- #285NVCR NovoCure Limited36.4 out of 100, No moatNo moat
- #286FOSL Fossil Group, Inc.36.3 out of 100, No moatNo moat
Compare LQDA with its nearest peers →All Healthcare companies on the Index →
Common questions about LQDA
- Does LIQUIDIA CORPORATION have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores LIQUIDIA CORPORATION (LQDA) 36.5 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 87, returns on capital 0, balance-sheet safety 28, capital discipline 24.
- How has LQDA's Moat Score changed over time?
- The record logs 3 readings since Jul 17, 2026; the latest reads 36.5 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.